31 studies found for:    " June 20, 2007":" July 20, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Withdrawn Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA016-00-VP;   Biological: VRC-HIVADV014-00-VP;   Biological: VRC-HIVDNA016-00-VP placebo;   Biological: VRC-HIVADV014-00-VP placebo
2 Completed
Has Results
Two Approaches to Routine HIV Testing in a Hospital Emergency Department
Condition: HIV Infections
Interventions: Behavioral: Counselor-based HIV screening;   Behavioral: Emergency staff member-based HIV screening
3 Completed
Has Results
Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors
Conditions: Substance Abuse;   HIV Infections
Interventions: Drug: mirtazapine;   Drug: placebo
4 Completed
Has Results
Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals
Conditions: Substance Abuse;   HIV Infections
Interventions: Drug: Aripiprazole;   Drug: Placebo
5 Completed Microbicides Acceptability Among Sexually Active Young Women
Condition: HIV Infections
Intervention: Behavioral: Automated diary system
6 Completed Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS
Condition: HIV Infections
Intervention: Biological: recombinant HIV-1 Tat protein
7 Completed Effects of HIV and Hepatitis C Virus on the Brain
Conditions: HIV Infections;   Hepatitis C
Intervention:
8 Completed Therapeutic Schools: Affect Management and HIV Prevention
Condition: HIV Infections
Interventions: Behavioral: Affect Management;   Behavioral: HIV Prevention Skills;   Behavioral: General Health Promotion
9 Completed HIV Prevention for Youth With Severe Mental Illness
Condition: HIV Infections
Intervention: Behavioral: Family-based HIV prevention program
10 Completed Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers
Condition: HIV Infections
Interventions: Biological: DNA-C;   Biological: NYVAC-C
11 Completed HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
Conditions: HIV Infections;   AIDS;   Lung Cancer;   Tobacco Addiction;   Drug Addiction
Intervention:
12 Completed Fanconi Syndrome Due to ARVs in HIV-Infected Persons
Conditions: HIV Infections;   Fanconi Syndrome;   Kidney Disease;   Renal Impairment
Intervention: Procedure: Blood Draws
13 Unknown  The Effect of Malaria on Disease Progression of HIV/AIDS
Conditions: HIV Infections;   Malaria
Interventions: Drug: mefloquine;   Other: placebo
14 Completed Growth Hormone in the Treatment of HIV-Associated Wasting
Conditions: HIV Infections;   HIV Wasting Syndrome
Intervention: Drug: Somatropin; Recombinant human growth hormone (r hGH)
15 Terminated Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients
Condition: HIV Infections
Intervention: Drug: KP-1461
16 Completed Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit Smoking
Conditions: Tobacco Dependence;   HIV Infections
Interventions: Behavioral: Standard Care Intervention (SCI);   Behavioral: Culturally Tailored Intervention (CTI)
17 Completed Management of Hepatitis C in HIV-Infected and Uninfected IDUs
Conditions: Hepatitis C Virus;   HIV Infections
Intervention: Drug: Peginterferon/Ribavirin
18 Completed Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Antiretroviral medications;   Drug: Antiretroviral medications+Isoniazid prophylaxis
19 Completed ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency
Conditions: HIV Infections;   Hepatitis B;   Dyslipidemia
Intervention: Drug: ProAlgaZyme
20 Completed An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
Conditions: HIV Infections;   HCV
Interventions: Drug: Albinterferon;   Drug: Ribavirin;   Drug: Albuferon

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Indicates status has not been verified in more than two years